Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-12-07

Clinical Trial Update: A Pharmacogenomic Exploration of Lacosamide Response

View source ↗

Summary

This document describes an ongoing pharmacogenomic study investigating how genetic factors influence lacosamide response in epilepsy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: Royal College of Surgeons, Ireland | Conditions: Epilepsy | Status: UNKNOWN